Acres Commercial Realty Corp
Real Estate
Acres Commercial Realty Corp (ACR) Stock News
The latest ACR headlines and market coverage — 5 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
Fate Therapeutics Selected for Four Presentations Highlighting its Off-the-Shelf CAR T-Cell Portfolio in Autoimmune Disease at ACR Convergence 2026
Fate Therapeutics announced that four abstracts from its off-the-shelf CAR T-cell programs have been selected for presentation at ACR Convergence 2026. The presentations will showcase clinical data for FT819, including administration without conditioning chemotherapy and outpatient administration capabilities, as well as updates on the Phase 1/2 COMPLETE Trial for FT839, a dual-CAR T-cell candidate targeting CD19 and CD38 for autoimmune diseases.
- GlobeNewswire Inc.·
Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
Nkarta, Inc. announced selection for three scientific presentations at ACR Convergence 2026 in November, including two oral presentations on NKX019's safety profile and clinical activity in idiopathic inflammatory myopathy, and one poster presentation on systemic sclerosis. The company is advancing NKX019, an allogeneic CAR-NK cell therapy targeting CD19 in B-cell-mediated autoimmune diseases, with enrollment ongoing in the Ntrust Phase 1/2 clinical trials across multiple indications.
- GlobeNewswire Inc.·Neutral
Landmark ECOG-ACRIN ENDURANCE Study Co-Authored by International Myeloma Foundation Leaders Provides Evidence for Optimal Duration of Maintenance Therapy
A phase III randomized trial published in the New England Journal of Medicine found that two years of lenalidomide maintenance therapy provides equivalent overall survival to indefinite treatment for standard-risk multiple myeloma patients. The study of 516 patients showed 68.6% vs 69.0% survival rates at seven years, with indefinite treatment associated with higher toxicity and second primary cancer incidence. Results suggest fixed-duration maintenance could become the new standard of care.
- GlobeNewswire Inc.·
LACROIX : Bilan semestriel du contrat de liquidité.
LACROIX Group released its H1 2026 liquidity contract report showing 5,256 shares and €73,233.86 in cash as of June 30, 2026. The company reported Q1 2026 revenue of €122.8 million, up 5.9% year-over-year, with stabilization in Electronics activity and strong growth in the Environment segment. The group is implementing a €77 million investment program.
- Benzinga·
ACRES Commercial Realty Corp. Declares Quarterly Cash Dividends for its Preferred Stock
ACRES Commercial Realty Corp. announced quarterly cash dividends on its preferred stock. The Series C Preferred Stock will pay $0.5993994 per share on July 30, 2026, while the Series D Preferred Stock will pay $0.4921875 per share on the same date. Both dividends reflect the company's commitment to returning capital to preferred shareholders.